Skip to main content
MIT Corporate Relations
MIT Corporate Relations
Search
×
Events
STEX25
Startups
opportunities
MIT ILP
Sign-In
Register Your Startup
Search
Search
×
STEX Home
Events
Corporates
Event Videos
Startups
STEX25
Featured
Videos
Startups
Search
News
opportunities
MIT ILP
User Menu and Search
Sign-In
Register Your Startup
Search
STEX Home
Toggle menu
Search
Sign-in
Register your startup
Events
Corporates
Event Videos
Startups
STEX25
Featured
Videos
Startups
Search
News
opportunities
MIT ILP
Cracking Cancer 2.0 - Industry/MIT Moment
Startup Exchange Video
|
Duration: 2:46
December 7, 2017
View this past event
Preview
Cracking Cancer 2.0 - Industry/MIT Moment - Erik Vogan
Please
login
to view this video.
Video details
Erik Vogan
, PhD, MBA
Program Director
MIT Corporate Relations Industrial Liaison Program
Locked Interactive transcript
Please
login
to view this video.
Video details
Erik Vogan
, PhD, MBA
Program Director
MIT Corporate Relations Industrial Liaison Program
Locked Interactive transcript
More Videos From This Event
See all videos
Thu, December 7, 2017
Cracking Cancer 2.0 - Welcome
Karl Koster
Executive Director
MIT Corporate Relations
Thu, December 7, 2017
Cracking Cancer 2.0 - Introductory Remarks
Cracking Cancer 2.0 - Introductory Remarks
Trond Undheim, PhD, Anne Deconinck, PhD
Thu, December 7, 2017
Cracking Cancer 2.0 - Cancer Innovation - The Long View
Paula Hammond, PhD
David H. Koch Professor in Engineering
Department Head, MIT Chemical Engineering
Koch Institute of Integrative Cancer Research Member
Thu, December 7, 2017
Cracking Cancer 2.0 - Lightning Talks
Startup lightning talks for Travera, Honeycomb, PanTher Therapeutics, Torque, Elektrofi;, Sextant, Leuko Labs, and Asimov.
Thu, December 7, 2017
Cracking Cancer 2.0 - Panel Discussion
Panel discussion moderated by Trond Undheim, Program Director, MIT Startup Exchange. Panelists include: Paula Hammond, PhD, David H. Koch Professor in Engineering, Department Head, Chemical Engineering, MIT, ; Laura Indolfi, PhD, CEO of PanTher Therapeutics; and Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.